Dynavax Technologies Corporation (NASDAQ:DVAX) Archives - BioPharmaJournal

Home Tags Dynavax Technologies Corporation (NASDAQ:DVAX)

Dynavax Technologies Corporation (NASDAQ:DVAX) Reports Record HEPLISAV-B® Vaccine Net Revenue Of...

Matt Wade - November 13, 2020 0

Dynavax Technologies’(NASDAQ:DVAX) Appoints Peter Paradiso To Board And Its CFO To...

Gavins Felicity - October 1, 2020 0

The Bill & Melinda Gates Foundation Grants Dynavax Technologies Corporation (NASDAQ:DVAX)...

Kate Hudson - August 19, 2020 0

TriSalus Life Sciences Enters into an Asset Purchase Agreement under Which...

Gavins Felicity - August 13, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX)’s Collaboration with Mount Sinai to Develop a...

Kate Hudson - July 23, 2020 0

12 Page 1 of 2

Recent Post

Banking stocks in focus

1606 Corp (CBDW) Expands into Artificial Intelligence with the Introduction of...

Matt Wade - November 2, 2023 0

The realm of artificial intelligence has been present for a while, yet it garnered heightened attention with the launch of ChatGPT and...

1606 Corp ($CBDW) Preps for Global Launch of Cutting-Edge ChatCBD AI-Driven...

October 26, 2023

Scientists working in a modern biotechnology laboratory, conducting cutting-edge research and developing innovative treatments

ImmunityBio ($IBRX) surges double digits and here’s why

October 24, 2023

Banking stocks in focus

Most Active Penny Stocks To Watch (BTE, MTC, WHEN, MDAI, MGUY)

October 20, 2023

Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,...

September 22, 2023